| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.18 | 0.4 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.4 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.4 |